Cargando…
Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family
BACKGROUND: In vitro pharmacology of ligands is typically assessed using a variety of molecular assays based on predetermined molecular events in living cells. Many ligands including opioid ligands pose the ability to bind more than one receptor, and can also provide distinct operational bias to act...
Autores principales: | Morse, Megan, Sun, Haiyan, Tran, Elizabeth, Levenson, Robert, Fang, Ye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602246/ https://www.ncbi.nlm.nih.gov/pubmed/23497702 http://dx.doi.org/10.1186/2050-6511-14-17 |
Ejemplares similares
-
Ligand-Directed Functional Selectivity at the Mu Opioid Receptor Revealed by Label-Free Integrative Pharmacology On-Target
por: Morse, Megan, et al.
Publicado: (2011) -
Pharmacological profiles of opioid ligands at Kappa opioid receptors
por: Gharagozlou, Parham, et al.
Publicado: (2006) -
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands
por: Sturaro, Chiara, et al.
Publicado: (2022) -
Label-free integrative pharmacology on-target of drugs at the β(2)-adrenergic receptor
por: Ferrie, Ann M., et al.
Publicado: (2011) -
Divergent Label-free Cell Phenotypic Pharmacology of Ligands at the Overexpressed β(2)-Adrenergic Receptors
por: Ferrie, Ann M., et al.
Publicado: (2014)